Paclitaxel potentiates inflammatory cytokine-induced prothrombotic molecules in endothelial cells

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 3, 2010, Pages 276-285

  Wood, Steven C ^a   Tang, Xing ^a   Tesfamariam, Belay ^b  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Adhesion molecules; Endothelial cells; Microparticles; Paclitaxel; Plasminogen activator inhibitor; Tissue factor; Tumor necrosis factor

Indexed keywords

CD31 ANTIGEN; CD59 ANTIGEN; PACLITAXEL; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

APOPTOSIS; ARTICLE; DRUG EFFECT; ENDOTHELIUM CELL; NITRATION; NITROTYROSINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN SECRETION; THROMBOSIS;

CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; NITRATES; PACLITAXEL; PLASMINOGEN INACTIVATORS; PROTEINS; THROMBOMODULIN; THROMBOPLASTIN; TUBULIN MODULATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951049705     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181d263f7     Document Type: Article

References (48)

1. Daub K, Lindemann S, Langer H, et al. The evil in atherosclerosis: adherent platelets induce foam cell formation. Semin Thromb Hemost. 2007;33:173-178.
2. Okamoto E, Couse T, De LH, et al. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation. 2001;104: 2228-2235.
3. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drugeluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435-2441.
4. Wood SC, Bushar G, Tesfamariam B. Inhibition of mammalian target of rapamycin modulates expression of adhesion molecules in endothelial cells. Toxicol Lett. 2006;165:242-249.
5. Ranade SV, Miller KM, Richard RE, et al. Physical characterization of controlled release of paclitaxel from the TAXUS Express 2 drug-eluting stent. J Biomed Mater Res A. 2004;71:625-634.
6. Vetrovec GW, Rizik D, Williard C, et al. Sirolimus PK trial: a pharmacokinetic study of the sirolimus-eluting Bx velocity stent in patients with de novo coronary lesions. Catheter Cardiovasc Interv. 2006; 67:32-37.
7. Branen L, Hovgaard L, Nitulescu M, et al. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2004;24:2137-2142.
8. Zhang L, Peppel K, Sivashanmugam P, et al. Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;25:1087-1094.
9. Canault M, Peiretti F, Mueller C, et al. Exclusive expression of transmembrane TNF-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus. Atherosclerosis. 2004;172:211-218.
10. Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol. 2005;25:1776-1785.
11. Kawano H, Tsuji H, Nishimura H, et al. Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells. Blood. 2001;97:1697-1702. (Pubitemid 32217236)
12. Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation. 2006;113: 722-731.
13. Liu Y, Pelekanakis K, Woolkalis MJ. Thrombin and tumor necrosis factor alpha synergistically stimulate tissue factor expression in human endothelial cells: regulation through c-Fos and c-Jun. J Biol Chem. 2004;279:36142-36147.
14. Zeerleder S, Hack CE, Wuillemin WA. Disseminated intravascular coagulation in sepsis. Chest. 2005;128:2864-2875.
15. Venkatraman S, Boey F. Release profiles in drug-eluting stents: issues and uncertainties. J Control Release. 2007;120:149-160.
16. Wang HJ, Huang H, Chuang YC, et al. Paclitaxel induces up-regulation of tissue factor in human aortic endothelial cells. Int Immunopharmacol. 2009;9:144-147.
17. Eisenreich A, Celebi O, Goldin-Lang P, et al. Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel. Int Immunopharmacol. 2008;8:307-311.
18. Stahli BE, Camici GG, Steffel J, et al. Paclitaxel enhances thrombininduced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ Res. 2006;99:149-155.
19. Napoleone E, Zurlo F, Latella MC, et al. Paclitaxel downregulates tissue factor in cancer and host tumour-associated cells. Eur J Cancer. 2009;45: 470-477.
20. Branen L, Hovgaard L, Nitulescu M, et al. Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2004;24:2137-2142.
21. Moos PJ, Fitzpatrick FA. Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. Proc Natl Acad Sci U S A. 1998;95:3896-3901.
22. Steffel J, Arnet C, Akhmedov A, et al. Histamine differentially interacts with tumor necrosis factor-alpha and thrombin in endothelial tissue factor induction: the role of c-Jun NH2-terminal kinase. J Thromb Haemost. 2006;4:2452-2460.
23. Muldowney JA III, Stringham JR, Levy SE, et al. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents. Arterioscler Thromb Vasc Biol. 2007;27:400-406.
24. Nan B, Lin P, Lumsden AB, et al. Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb Res. 2005;115:417-426. (Pubitemid 40283487)
25. Miller DL, Yaron R, Yellin MJ. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J Leukoc Biol. 1998;63:373-379.
26. Esmon CT. The endothelial cell protein C receptor. Thromb. Haemost. 2000;83:639-643.
27. Nan B, Lin P, Lumsden AB, et al. Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb Res. 2005;115:417-426. (Pubitemid 40283487)
28. Shimokawa T, Yamamoto K, Kojima T, et al. Down-regulation of murine tissue factor pathway inhibitor mRNA by endotoxin and tumor necrosis factor-alpha in vitro and in vivo. Thromb Res. 2000;100:211-221.
29. Ameri A, Kuppuswamy MN, Basu S, et al. Expression of tissue factor pathway inhibitor by cultured endothelial cells in response to inflammatory mediators. Blood. 1992;79:3219-3226.
30. Wong D, Dorovini-Zis K. Platelet/endothelial cell adhesion molecule-1 (PECAM-1) expression by human brain microvessel endothelial cells in primary culture. Brain Res. 1996;731:217-220. (Pubitemid 26294927)
31. Davis HW, VandenBerg E, Reid MD, et al. Paclitaxel impairs endothelial cell adhesion but not cytokine-induced cellular adhesion molecule expression. Ann Vasc Surg. 2005;19:398-406.
32. Lehmann I, Brylla E, Sittig D, et al. Microvascular endothelial cells differ in their basal and tumour necrosis factor-alpha-regulated expression of adhesion molecules and cytokines. J Vasc. Res. 2000;37:408-416.
33. Oostingh GJ, Schlickum S, Friedl P, et al. Impaired induction of adhesion molecule expression in immortalized endothelial cells leads to functional defects in dynamic interactions with lymphocytes. J Invest Dermatol. 2007;127:2253-2258.
34. VandenBerg E, Reid MD, Edwards JD, et al. The role of the cytoskeleton in cellular adhesion molecule expression in tumor necrosis factorstimulated endothelial cells. J Cell Biochem. 2004;91:926-937.
35. Min W, Pober JS. TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-kappa B and TRAF-RAC/ CDC42-JNK-c-Jun/ATF2 pathways. J Immunol. 1997;159:3508-3518.
36. Prasad CK, Resmi KR, Krishnan LK, et al. Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents. J Biomater Appl 2005;19: 271-286.
37. Jy W, Jimenez JJ, Mauro LM, et al. Agonist-induced capping of adhesion proteins and microparticle shedding in cultures of human renal microvascular endothelial cells. Endothelium. 2002;9:179-189.
38. Inoue T, Komoda H, Kotooka N, et al. Increased circulating plateletderived microparticles are associated with stent-induced vascular inflammation. Atherosclerosis. 2008;196:469-476.
39. VanWijk MJ, VanBavel E, Sturk A, et al. Microparticles in cardiovascular diseases. Cardiovasc Res. 2003;59:277-287.
40. VanWijk MJ, VanBavel E, Sturk A, et al. Microparticles in cardiovascular diseases. Cardiovasc Res. 2003;59:277-287.
41. Martin S, Tesse A, Hugel B, et al. Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation. 2004;109:1653-1659.
42. Jimenez JJ, Jy W, Mauro LM, et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res. 2003;109:175-180.
43. Simak J, Holada K, Vostal JG. Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin. BMC Cell Biol. 2002;3:11.
44. Morel O, Toti F, Hugel B, et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol. 2006; 26:2594-2604.
45. Murphy HS, Shayman JA, Till GO, et al. Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways. Am J Physiol. 1992;263:L51-L59.
46. Wang W, Wang S, Yan L, et al. Superoxide production and reactive oxygen species signaling by endothelial nitric-oxide synthase. J Biol Chem. 2000;275:16899-16903.
47. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315-424.
48. Phelps DT, Ferro TJ, Higgins PJ, et al. TNF-alpha induces peroxynitritemediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol. 1995;269:L551-L559.